Revolution Medicines (RVMD) Prepaid Assets (2019 - 2026)
Revolution Medicines' quarterly Prepaid Assets came in at $59.8 million in Q1 2026, up 87.51% year-on-year from $31.9 million in Q1 2025, and up 21.21% quarter-over-quarter from $49.4 million in Q4 2025.
Revolution Medicines has reported Prepaid Assets for 8 years, with the latest figure at $59.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 87.51% year-over-year to $59.8 million; the trailing twelve-month figure through Mar 2026 stood at $59.8 million (up 87.51% YoY), and the FY2025 full-year result was $49.4 million, up 28.76% from the prior year.
- Prepaid Assets for Q1 2026 stood at $59.8 million, up from $49.4 million in the prior quarter.
- The five-year high for Prepaid Assets was $59.8 million in Q1 2026, with the low at $9.0 million in Q1 2023.
- Average Prepaid Assets over 5 years is $27.1 million, with a median of $25.7 million recorded in 2024.
- Year-over-year, Prepaid Assets sank 36.88% in 2023 and jumped 237.02% in 2024.
- Tracing RVMD's Prepaid Assets over 5 years: stood at $10.6 million in 2022, then surged by 137.22% to $25.1 million in 2023, then jumped by 52.89% to $38.3 million in 2024, then grew by 28.76% to $49.4 million in 2025, then climbed by 21.21% to $59.8 million in 2026.
- The last three Prepaid Assets figures came in at $59.8 million (Q1 2026), $49.4 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.83 Mn |
| Dec 31, 2025 | 49.36 Mn |
| Sep 30, 2025 | 45.98 Mn |
| Jun 30, 2025 | 39.27 Mn |
| Mar 31, 2025 | 31.91 Mn |
| Dec 31, 2024 | 38.33 Mn |
| Sep 30, 2024 | 29.66 Mn |
| Jun 30, 2024 | 34.02 Mn |
| Mar 31, 2024 | 25.66 Mn |
| Dec 31, 2023 | 25.07 Mn |
| Sep 30, 2023 | 10.96 Mn |
| Jun 30, 2023 | 10.09 Mn |
| Mar 31, 2023 | 8.96 Mn |
| Dec 31, 2022 | 10.57 Mn |
| Sep 30, 2022 | 15.16 Mn |
| Jun 30, 2022 | 15.99 Mn |
| Mar 31, 2022 | 10.21 Mn |
| Dec 31, 2021 | 6.79 Mn |
| Sep 30, 2021 | 7.47 Mn |
| Jun 30, 2021 | 8.16 Mn |
| Mar 31, 2021 | 8.25 Mn |
| Dec 31, 2020 | 6.99 Mn |
| Sep 30, 2020 | 7.46 Mn |
| Jun 30, 2020 | 7.61 Mn |
| Mar 31, 2020 | 5.69 Mn |
| Dec 31, 2019 | 2.49 Mn |